The Paired Box (PAX) family of transcription factors plays a crucial role in the regulation of gene expression during development and tissue maintenance in a variety of organisms, from invertebrates to humans. PAX proteins generally contain a paired domain, a conserved DNA-binding motif, and some family members also have a homeodomain and other domains that contribute to transcriptional regulation. These transcription factors act as master regulators in a range of developmental processes including neural development, formation of various tissues, and organogenesis. PAX proteins can either activate or repress target genes, and they often work in concert with other transcription factors and signaling pathways to exert precise control over developmental processes. Dysregulation of PAX signaling is associated with various developmental disorders and malignancies, illustrating their essential role in cellular function and organismal development.
Paired Box (PAX) Inhibitors are a category of chemical compounds designed to modulate the activity of PAX transcription factors, which are integral to a variety of cellular processes including differentiation, development, and cellular proliferation. These inhibitors usually act by interfering with the DNA-binding capability of PAX proteins, thereby suppressing their ability to regulate target genes. Various methods, such as high-throughput screening and computational modeling, have been employed to discover and optimize molecules that can effectively bind to the paired domain or other functional domains of PAX proteins.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Chetomin | 1403-36-7 | sc-202535 sc-202535A | 1 mg 5 mg | $186.00 $674.00 | 10 | |
A fungal metabolite that may inhibit Paired Box (PAX)-mediated transcriptional activation by interacting with its DNA-binding domain. | ||||||
Ethyl 2-amino-6-benzyl-4,5,6,7-tetrahydrothieno [2,3-c]pyridine-3-carboxylate | 24237-54-5 | sc-285521 sc-285521A | 5 g 25 g | $188.00 $525.00 | ||
An antifungal compound that could potentially impact Paired Box (PAX) function and gene expression, affecting neural development. | ||||||
FTY720 | 162359-56-0 | sc-202161 sc-202161A sc-202161B | 1 mg 5 mg 25 mg | $33.00 $77.00 $120.00 | 14 | |
A sphingosine-1-phosphate receptor modulator that might affect Paired Box (PAX) expression and signaling pathways involved in neural development. | ||||||
Cryptotanshinone | 35825-57-1 | sc-280649 | 10 mg | $119.00 | 1 | |
A natural compound with potential inhibitory effects on Paired Box (PAX) expression, potentially affecting neural development. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
An inhibitor of DNA methyltransferases that could impact Paired Box (PAX) expression and epigenetic regulation in neural cells. | ||||||
BIX01294 hydrochloride | 1392399-03-9 | sc-293525 sc-293525A sc-293525B | 1 mg 5 mg 25 mg | $37.00 $112.00 $408.00 | ||
An inhibitor of G9a histone methyltransferase that may modulate Paired Box (PAX) expression through epigenetic regulation. | ||||||
Ibrutinib | 936563-96-1 | sc-483194 | 10 mg | $156.00 | 5 | |
Although not a direct Paired Box (PAX) inhibitor, ibrutinib is a Bruton's tyrosine kinase (BTK) inhibitor that affects B-cell signaling pathways, which indirectly impacts Paired Box (PAX) activity. | ||||||
CAL-101 | 870281-82-6 | sc-364453 | 10 mg | $193.00 | 4 | |
CAL-101 is a phosphoinositide 3-kinase (PI3K) inhibitor that targets B-cell signaling pathways, affecting Paired Box (PAX) indirectly. | ||||||
Lenalidomide | 191732-72-6 | sc-218656 sc-218656A sc-218656B | 10 mg 100 mg 1 g | $50.00 $374.00 $2071.00 | 18 | |
Although not a direct Paired Box (PAX) inhibitor, lenalidomide can affect B-cell function and survival, potentially influencing Paired Box (PAX) activity. | ||||||